首页> 外文期刊>Journal of vascular surgery >Thirty-day outcomes after fenestrated endovascular repair are superior to open repair of abdominal aortic aneurysms involving visceral vessels
【24h】

Thirty-day outcomes after fenestrated endovascular repair are superior to open repair of abdominal aortic aneurysms involving visceral vessels

机译:腹腔罩修复后三十天的结果优于开放的修复涉及内脏血管的腹主动脉瘤

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Objective Although few studies have reported outcomes after branched or fenestrated endovascular aortic aneurysm repair (FEVAR) of abdominal aortic aneurysms involving visceral vessels (AAA-Vs), no multi-institutional study has compared FEVAR with open surgery (OS) for AAA-Vs. Our objective was to compare 30-day outcomes after FEVAR vs OS for AAA-Vs. Methods Patients who underwent FEVAR (n? 535) and OS (n? 1207) for elective AAA-Vs were identified from the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) 2008 to 2013 database. Thoracoabdominal aneurysms were excluded. Univariable and multivariable logistic regression analyses were performed. Results There were more men (82% vs 72%; P ?P ? .005), patients with dependent functional status (4% vs 2%; P ? .002), and nonsmokers (70% vs 56%; P ?P > .05). FEVAR had fewer major postoperative pulmonary complications (3.0% vs 19.0%; P ?P ?P ??001), less bleeding with major transfusion (17.4% vs 50.2%; P ?P ?P ? .02). The median length of stay was also significantly shorter for FEVAR (2燿ays vs 7燿ays; P ?Conclusions FEVAR is associated with a lower risk for 30-day mortality and adverse events compared with OS for AAA-Vs.
机译:摘要目的虽然涉及内脏血管(AAA-VS)的腹主动脉瘤(AAA-VS)的分支或肠道血管内动脉瘤修复(FEVAR)甚至几次研究报告了结果,但没有多制度研究与AAA-VS的开放手术(OS)与FEVAR进行了比较。我们的目标是在FEVAR与AAA-VS后进行30天的结果。方法从美国外科医生大学外科医院(NSQIP)2008年至2013年数据库中识别出于选择性AAA-VS的FEVAR(N?535)和OS(N?1207)的患者。排除了胸腔内动脉瘤。进行了不可变化和多变量的逻辑回归分析。结果有更多的男性(82%vs 72%; p?p≤005),患者患者功能状态(4%vs 2%; p?.002)和非闻名者(70%与56%; p?p > .05)。 FEVAR具有较少的主要术后肺并发症(3.0%vs 19.0%; p?p?p ?? 001),具有重大输血的较小流出(17.4%Vs 50.2%;p≤p≤p≤02)。 FEVAR的中位数的逗留时间也明显缩短了(2‰Ays与7耀any; p?结论FEVAR与30天死亡率和不良事件的风险较低,与AAA-VS相比。

著录项

  • 来源
    《Journal of vascular surgery》 |2017年第6期|共6页
  • 作者单位

    Division of Vascular and Endovascular Surgery University of Tennessee Health Science Center;

    Division of Vascular and Endovascular Surgery University of Tennessee Health Science Center;

    Division of Vascular and Endovascular Surgery University of Tennessee Health Science Center;

    Division of Vascular and Endovascular Surgery University of Tennessee Health Science Center;

    Division of Vascular and Endovascular Surgery University of Tennessee Health Science Center;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 心脏血管和淋巴系外科学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号